Maastricht University Medical Center: Insulin Resistance trials

The registry lists 36 Insulin Resistance studies with Maastricht University Medical Center as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 3 1Phase 4 1No phase 34(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Targeted Precision Nutrition Strategy To Prevent Chronic Metabolic DiseasesRecruitingNCT06923644Not applicable
• Effects of Ketone Monoesters on Brain FunctionCompletedNCT06395051Not applicable
• Acute Microbial SwitchCompletedNCT05764200Not applicable
• Effects of Peanut Consumption on Brain FunctionCompletedNCT05724654Not applicable
• Personalized Fiber and Insulin SensitivityCompletedNCT05378295Not applicable
• Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL)CompletedNCT05354245Not applicable
• Effect of Dietary SFA and Fructose on Hepatic Insulin SensitivityCompletedNCT05017675Not applicable
• Determination of Insulin-stimulated Hepatic Glucose Uptake by PET-CT MeasurementsStatus unknownNCT04938544
• Human Milk Oligossaccharide and Acetate Production in VivoCompletedNCT04795804Not applicable
• Fiber and Insulin SensitivityCompletedNCT04714944Not applicable
• Nitrate and Brain Insulin-SensitivityCompletedNCT04700241Not applicable
• Carbohydrate-induced Resilience of the Gut Microbiome After Antibiotics UseCompletedNCT04561284Not applicable
• Hypoxic Exercise and Glucose MetabolismCompletedNCT04280991Not applicable
• Nutritional Supplementation and Insulin SensitivityTerminatedNCT04239482Not applicable
• Restriction of Dietary AGEs to Prevent Diabetes in Overweight IndividualsCompletedNCT03866343Not applicable
• Ciprofibrate and Pre-diabetesCompletedNCT03662984Phase 3
• Determinants of Liver Fat CompositionCompletedNCT03211299
• Effect of Pyridoxamine Supplementation on Vascular Function and Insulin SensitivityCompletedNCT02954588Not applicable
• Nicotinamide Riboside and Metabolic HealthCompletedNCT02835664Not applicable
• Carnitine Infusion and Insulin ResistanceTerminatedNCT02722902Not applicable
• Circadian Misalignment and Insulin SensitivityCompletedNCT02580513Not applicable
• Bedrest, Feeding Pattern, and Insulin SensitivityCompletedNCT02521025Not applicable
• SIT LESS 3: The Effect of Low Intensity Physical Activity on Insulin Sensitivity, Mood and Cognitive PerformanceCompletedNCT02394249Not applicable
• GOS and Insulin SensitivityCompletedNCT02271776Not applicable
• Day-Night Rhythm in Human Skeletal MuscleCompletedNCT02261168Not applicable
• The Importance of the Gut Microbiota in Body Weight Control and Insulin SensitivityCompletedNCT02241421Not applicable
• Bed-rest, Muscle Mass and Insulin SensitivityCompletedNCT02109380Not applicable
• Aldosterone, Microvascular Function and Salt-sensitivityCompletedNCT02068781Not applicable
• Aldosterone Antagonism and Microvascular FunctionTerminatedNCT01887119Phase 4
• The Effect of Lowered Physical Activity on Insulin Sensitivity and Lipid and Glucose MetabolismCompletedNCT01576250Not applicable
• Lipids and Insulin SensitivityCompletedNCT01466816Not applicable
• Dietary Polyphenols and Lipid OxidationCompletedNCT01302639Not applicable
• NEAT and Insulin SensitivityCompletedNCT01299311Not applicable
• Effect of Feeding Frequency on Glucose and Insulin Metabolism and Substrate PartitioningCompletedNCT01034293Not applicable
• Role of Angiotensin II in Insulin-induced Microvascular ActivityCompletedNCT01024543Not applicable
• Role of AT1-receptor Blockers in Insulin-induced Vasodilation.Status unknownNCT00742066Not applicable